Top Industry Leaders in the Retinal Detachment treatment Market
Roche Received FDA approval for Vabysmo (faricimab) as a treatment for diabetic macular edema (DME) and wet age-related macular degeneration (wet AMD). While not directly for retinal detachment, Vabysmo's potential to prevent these conditions, which can lead to retinal detachment, is noteworthy.
Sentientis Surgical Secured $50 million in Series C funding to advance its development of the SupraChoroid™ Elutes delivery system for sustained drug delivery to the back of the eye, offering a potential novel approach for treating retinal detachment and other eye diseases.
Alcon Laboratories Launched the EDOF IOL (AcrySof IQ PanOptix Trifocal IOL) in the US, providing an extended depth of focus intraocular lens that can improve vision after cataract surgery, potentially reducing the need for additional interventions like retinal detachment surgery.
List of Retinal Detachment treatment Key Companies in the Market
- Carl Zeiss Meditec AG
- Meridian AG
- IRIDEX Corporation
- Ellex Medical Lasers Ltd
- FCI
- Millennium Surgical Corp.
- BVM Medical Limited
- Lombart Instrument, Inc.
- Welch Allyn